REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

TaiRx, Inc. (台睿生物科技股份有限公司) (Taiwan, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: TaiRx, Inc. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

TaiRx, Inc. is mainly engaged in medical pharmacy. The company's pharmaceutical products include anti-cancer, sepsis and so on. TaiRx was established in 2011 and located in Taipei City.

Headquarters
6F-1, No. 66, San-Chung Road, Nankang Dist
Taipei City; Taipei City;

Contact Details: Purchase the TaiRx, Inc. (台睿生物科技股份有限公司) report to view the information.

Website: http://www.trx.com.tw

Basic Information
Total Employees:
Purchase the TaiRx, Inc. (台睿生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the TaiRx, Inc. (台睿生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the TaiRx, Inc. (台睿生物科技股份有限公司) report to view the information.
Incorporation Date:
August 22, 2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Senior Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
9.73%
Purchase this report to view the information.
0.67%
Purchase this report to view the information.
0.61%
Purchase this report to view the information.
0.55%
Purchase this report to view the information.
0.52%
Subsidiaries
Tairx Pharmaceuticals Co., Ltd. (Samoa)
100%
Tairx Us, Inc. (United States)
94.12%
Company Performance
Financial values in the chart are available after TaiRx, Inc. (台睿生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
2731.7%▲
Total operating revenue
2731.7%▲
Operating profit (EBIT)
-4.97%▼
EBITDA
-2.38%▼
Net Profit (Loss) for the Period
-4.39%▼
Total Assets
-18.73%▼
Total Equity
-18.85%▼
Operating Profit Margin (ROS)
27421.4%▲
Net Profit Margin
26108.22%▲
Return on Equity (ROE)
-2.89%▼
Debt/Equity
-0.25%▼
Quick Ratio
-3.59%▼
Cash Ratio
-0.03%▼

Similar companies

Syngen Biotech Co., Ltd.
 
CH Biotech R&D Co., Ltd.
Medigen Biotechnology Corporation
 
EirGenix Inc.
Glac Biotech Co., Ltd. (Tainan City) (丰华生物科技 (台南市))
 
Ever Supreme Bio Technology Co., Ltd.
Energenesis Biomedical CO.,Ltd.
 
Health Ever Bio-Tech Co., Ltd. (Taipei) (健永生技股份有限公司(台北市))
Metagone Biotech Inc.
 
Senhwa Biosciences, Inc.
Great Novel Therapeutics Biotech & Medic
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo